Đang chuẩn bị liên kết để tải về tài liệu:
Comparing the efficacy and side-effects of PDLASTA® (Pegfilgrastim) with PDGRASTIM® (Filgrastim) in breast cancer patients: A non-inferiority randomized clinical trial
Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
The objective of this study was to compare the efficacy and side effects of a single dose (Pegfilgrastim or PDL) or repeated six daily injections (Filgrastim or PDG) during chemotherapy courses in breast cancer patients in a non-inferiority clinical trial. |